USP17L27 Gene: Ubiquitin-Specific Peptidase 17-Like Family Member 27
A duplicated deubiquitinase gene with potential roles in cancer and immune regulation
Gene Information Card
| Symbol | USP17L27 |
|---|---|
| Full Name | ubiquitin specific peptidase 17 like family member 27 |
| Gene Type | protein-coding |
| Chromosomal Location | 4p16.1 (within a cluster of USP17-like genes) |
| NCBI Gene ID | 100287485 ncbi.nlm.nih.gov/gene/100287485 |
| Ensembl ID | ENSG00000230502 |
| UniProt ID | A6NK89 |
| OMIM ID | None assigned |
| HGNC ID | 44437 |
| Aliases | USP17L27, DUB-3-like, hDUB-3-like |
Description
USP17L27 is a protein-coding gene that belongs to the USP17 family of deubiquitinating enzymes. It is located on chromosome 4p16.1, within a cluster of highly similar USP17-like genes that arose through segmental duplication. The encoded protein contains a peptidase C19 domain characteristic of ubiquitin-specific proteases, which cleave ubiquitin from target proteins, thereby regulating protein stability and signaling pathways. USP17L27 is part of a gene family implicated in cell proliferation, apoptosis, and immune responses. However, due to its high sequence similarity to other USP17 family members, functional studies often require careful discrimination. The gene is expressed in various tissues and may be upregulated in certain cancers, suggesting a potential role in tumorigenesis, though specific disease associations are still under investigation.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (general) | Potential oncogenic role via deubiquitination of substrates involved in cell cycle and apoptosis; overexpression observed in some tumors. | COSMIC (cancer.sanger.ac.uk) shows mutations/expression changes in various cancer types; literature suggests USP17 family involvement. |
| Immune-related disorders | USP17 family members regulate cytokine signaling and T-cell responses; dysregulation may contribute to inflammatory conditions. | Inferred from functional studies of USP17 family; direct evidence for USP17L27 is limited. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | Not available | Low expression (based on EST data) |
| Lymph node | Not available | Moderate expression (based on EST data) |
| Bone marrow | Not available | Low expression (based on EST data) |
| Other tissues | Not available | Expression data limited; USP17 family members are broadly expressed but at low levels. |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | Not available | USP17 family members are expressed; specific USP17L27 not distinguished. |
| HEK293 | Not available | Commonly used for overexpression studies of USP17 family. |
| Jurkat | Not available | T-cell line; USP17 family implicated in immune signaling. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | Rare (COSMIC) | Potential loss of start codon, affecting translation. |
| c.100C>T (p.Arg34Trp) | Missense | Rare (COSMIC) | May affect catalytic activity or stability. |
| c.250G>A (p.Asp84Asn) | Missense | Rare (COSMIC) | Located in peptidase domain; possible functional impact. |
Mutation functional classification
Loss of Function (LOF)
Mutations that disrupt the catalytic cysteine or histidine residues in the peptidase domain would likely abolish deubiquitinase activity, leading to accumulation of ubiquitinated substrates and altered signaling.
Gain of Function (GOF)
Amplification or overexpression of USP17L27 could enhance deubiquitination of substrates, promoting cell proliferation or survival, as seen in some cancers.
Dominant Negative (DN)
A mutant USP17L27 that retains substrate binding but lacks catalytic activity could compete with wild-type USP17 family members, blocking their function.
View complete mutation data:
Gene Ontology (GO)
| • cysteine-type peptidase activity | • ubiquitin-specific protease activity |
| • proteolysis | • ubiquitin-dependent protein catabolic process |
| • regulation of cell proliferation | • regulation of apoptotic process |
Pathways
• Ubiquitin-proteasome pathway
• Cytokine signaling (e.g.
• JAK-STAT)
• Cell cycle regulation
Protein Summary
The USP17L27 protein is a deubiquitinating enzyme that removes ubiquitin from specific target proteins, thereby preventing their degradation by the proteasome. It contains a conserved peptidase C19 domain. Its precise substrates are not fully characterized, but USP17 family members are known to regulate proteins involved in cell cycle progression, apoptosis, and immune signaling. Due to its high similarity to other USP17 proteins, functional redundancy is likely.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| USP17L27 Knockout HEK293 Cell Line | EDJ-KQ16070 | Human | 728393 | Details Get a Quote |
| USP17L27 Knockout A-549 Cell Line | EDJ-KQ47187 | Human | 728393 | Details Get a Quote |
| USP17L27 Knockout HCT 116 Cell Line | EDJ-KQ47188 | Human | 728393 | Details Get a Quote |
| USP17L27 Knockout HeLa Cell Line | EDJ-KQ47189 | Human | 728393 | Details Get a Quote |